Evaluation of a Digital Therapy of Auditory Training
Launched by HUMANS MATTER · Apr 27, 2023
Trial Information
Current as of July 01, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new digital therapy called AUDISSEE, which is designed to help improve the ability to hear and understand speech in noisy environments for older adults who have age-related hearing loss (known as presbycusis) and use hearing aids. The goal is to see how effective this device is for those who may struggle to hear clearly when there is background noise.
To participate in the trial, individuals must be at least 18 years old and have been diagnosed with presbycusis by a healthcare professional. They should also have been using hearing aids for less than two years and must not have any major cognitive issues or other serious health conditions. Participants will need access to a personal computer, tablet, or smartphone to complete the training exercises. This study is currently not recruiting participants, but if you or a family member meet these criteria and are motivated to improve your hearing, this trial could be a promising opportunity once it starts.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age over 18
- • No neurological or psychiatric background
- • No major cognitive deficit, able to understand and apply the recommendation
- • Motivated to participate
- • Have given its written consent
- • Affiliated to a social security system
- • Diagnostic of presbycusis by a health professional
- • Hearing-aids since less than 2 years (no cochlear implants)
- • No tinnitus
- • With a possible access to a personal computer, tactile tablet or smart-phone to perform the training
- Exclusion Criteria:
- • Age below 18
- • Pregnant or breastfeeding women
About Humans Matter
Humans Matter is a dedicated clinical trial sponsor focused on advancing healthcare through innovative research and development. Committed to improving patient outcomes, the organization emphasizes ethical practices and patient-centric approaches in its clinical trials. By fostering collaboration among researchers, healthcare professionals, and participants, Humans Matter aims to generate robust clinical evidence that informs treatment options and enhances quality of life. Their mission is to ensure that the voice of the patient is at the forefront of every study, driving meaningful advancements in medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
agathe pralus, PhD
Study Chair
Humans Matter
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported